NOVAVAX INC

NVAX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001104659-26-023731
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Kelly James Patrick (CFO)

Summary

Type

Sell

Net shares

-20,850

% of shares

-14.37%

Amount (USD)

$197,866

Insider confidence score

42.5 out of 100

Positive

  • Tax withholding obligation

Negative

  • Large tax withholding sell (≥1% of shares)
  • Significant sell amount ($50K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+43,167.0

Acquired/Disposed

Acquired

Shares Owned Before

101,963.0

Shares Owned After

145,130.0

Transaction 2

Security

Common Stock

Action

Tax_withhold

Date

2026-03-03

Code

F

Net shares

-20,850.0

Price per Share

$9.49

Amount (USD)

$197,866.50

Acquired/Disposed

Disposed

Shares Owned Before

145,130.0

Shares Owned After

124,280.0

Derivative Transactions

Transaction 1

Security

Restricted Stock Units

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-43,167.0

Acquired/Disposed

Disposed

Shares Owned Before

129,500.0

Shares Owned After

86,333.0

Filing's footnotes

1. Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.

2. One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on each of the first three (3) anniversaries of March 1, 2024, in each case subject to continued employment through such vesting date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.